Farther Finance Advisors’s Elicio Therapeutics ELTX Stock Holding History

Farther Finance Advisors’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.7K	Buy	947 +226	+31%	+$2.27K	﹤0.01%	4948
2026 Q1	$7.69K	Buy	721 +16	+2%	+$154	﹤0.01%	4274
2025 Q4	$5.61K	Buy	705 +65	+10%	+$590	﹤0.01%	4244
2025 Q3	$7K	Buy	+640	New	+$6.48K	﹤0.01%	3609

Other funds holding ELTX

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MFA

Mayflower Financial Advisors Boston, Massachusetts $1.16B AUM 24.36% 1-Year Est. Return

MLL

Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Farther Finance Advisors's ELTX Position: Q2 2026 in Review

Farther Finance Advisors increased its Elicio Therapeutics (ELTX) stake by 31% in Q2 2026, buying an estimated $2.27K and bringing the position to 947 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4948.

Farther Finance Advisors first reported a position in ELTX in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.69K in Q1 2026. 5 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

Farther Finance Advisors held 947 shares of Elicio Therapeutics worth $3.7K as of Q2 2026.
Farther Finance Advisors bought 226 Elicio Therapeutics shares in Q2 2026, an estimated $2.27K.
Elicio Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4948 holding.
Farther Finance Advisors first reported a position in Elicio Therapeutics in Q3 2025 and has held it in 4 quarters since.
Farther Finance Advisors's Elicio Therapeutics position peaked at $7.69K in Q1 2026.
5 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.